Global Immune Checkpoint Inhibitors Market Growth Insights By Types (CTLA-4 Inhibitor, PD-1 Inhibitor, PD-L1 Inhibitor, Others), By Applications Covered (Lung Cancer, Breast Cancer, Liver Cancer, Gastric Cancer, Glioma Cancer, Esophageal Cancer, Others) & Region - Forecast to 2031

Detailed TOC of Global Immune Checkpoint Inhibitors Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2031

Table of Content

1 Immune Checkpoint Inhibitors Market Overview
1.1 Product Overview and Scope of Immune Checkpoint Inhibitors Market
1.2 Immune Checkpoint Inhibitors Market Segment by Type
1.2.1 Global Immune Checkpoint Inhibitors Market Sales Volume and CAGR (%) Comparison by Type (2017-2031)
1.3 Global Immune Checkpoint Inhibitors Market Segment by Application
1.3.1 Immune Checkpoint Inhibitors Market Consumption (Sales Volume) Comparison by Application (2017-2031)
1.4 Global Immune Checkpoint Inhibitors Market, Region Wise (2017-2031)
1.4.1 Global Immune Checkpoint Inhibitors Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2031)
1.4.2 United States Immune Checkpoint Inhibitors Market Status and Prospect (2017-2031)
1.4.3 Europe Immune Checkpoint Inhibitors Market Status and Prospect (2017-2031)
1.4.4 China Immune Checkpoint Inhibitors Market Status and Prospect (2017-2031)
1.4.5 Japan Immune Checkpoint Inhibitors Market Status and Prospect (2017-2031)
1.4.6 India Immune Checkpoint Inhibitors Market Status and Prospect (2017-2031)
1.4.7 Southeast Asia Immune Checkpoint Inhibitors Market Status and Prospect (2017-2031)
1.4.8 Latin America Immune Checkpoint Inhibitors Market Status and Prospect (2017-2031)
1.4.9 Middle East and Africa Immune Checkpoint Inhibitors Market Status and Prospect (2017-2031)
1.5 Global Market Size of Immune Checkpoint Inhibitors (2017-2031)
1.5.1 Global Immune Checkpoint Inhibitors Market Revenue Status and Outlook (2017-2031)
1.5.2 Global Immune Checkpoint Inhibitors Market Sales Volume Status and Outlook (2017-2031)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Immune Checkpoint Inhibitors Market

2 Industry Outlook
2.1 Immune Checkpoint Inhibitors Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Immune Checkpoint Inhibitors Market Drivers Analysis
2.4 Immune Checkpoint Inhibitors Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Immune Checkpoint Inhibitors Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Immune Checkpoint Inhibitors Industry Development

3 Global Immune Checkpoint Inhibitors Market Landscape by Player
3.1 Global Immune Checkpoint Inhibitors Sales Volume and Share by Player (2017-2022)
3.2 Global Immune Checkpoint Inhibitors Revenue and Market Share by Player (2017-2022)
3.3 Global Immune Checkpoint Inhibitors Average Price by Player (2017-2022)
3.4 Global Immune Checkpoint Inhibitors Gross Margin by Player (2017-2022)
3.5 Immune Checkpoint Inhibitors Market Competitive Situation and Trends
3.5.1 Immune Checkpoint Inhibitors Market Concentration Rate
3.5.2 Immune Checkpoint Inhibitors Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion

4 Global Immune Checkpoint Inhibitors Sales Volume and Revenue Region Wise (2017-2022)
4.1 Global Immune Checkpoint Inhibitors Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Immune Checkpoint Inhibitors Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Immune Checkpoint Inhibitors Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Immune Checkpoint Inhibitors Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Immune Checkpoint Inhibitors Market Under COVID-19
4.5 Europe Immune Checkpoint Inhibitors Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Immune Checkpoint Inhibitors Market Under COVID-19
4.6 China Immune Checkpoint Inhibitors Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Immune Checkpoint Inhibitors Market Under COVID-19
4.7 Japan Immune Checkpoint Inhibitors Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Immune Checkpoint Inhibitors Market Under COVID-19
4.8 India Immune Checkpoint Inhibitors Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Immune Checkpoint Inhibitors Market Under COVID-19
4.9 Southeast Asia Immune Checkpoint Inhibitors Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Immune Checkpoint Inhibitors Market Under COVID-19
4.10 Latin America Immune Checkpoint Inhibitors Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Immune Checkpoint Inhibitors Market Under COVID-19
4.11 Middle East and Africa Immune Checkpoint Inhibitors Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Immune Checkpoint Inhibitors Market Under COVID-19

5 Global Immune Checkpoint Inhibitors Sales Volume, Revenue, Price Trend by Type
5.1 Global Immune Checkpoint Inhibitors Sales Volume and Market Share by Type (2017-2022)
5.2 Global Immune Checkpoint Inhibitors Revenue and Market Share by Type (2017-2022)
5.3 Global Immune Checkpoint Inhibitors Price by Type (2017-2022)
5.4 Global Immune Checkpoint Inhibitors Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Immune Checkpoint Inhibitors Sales Volume, Revenue and Growth Rate of CTLA-4 Inhibitor (2017-2022)
5.4.2 Global Immune Checkpoint Inhibitors Sales Volume, Revenue and Growth Rate of PD-1 Inhibitor (2017-2022)
5.4.3 Global Immune Checkpoint Inhibitors Sales Volume, Revenue and Growth Rate of PD-L1 Inhibitor (2017-2022)
5.4.4 Global Immune Checkpoint Inhibitors Sales Volume, Revenue and Growth Rate of Others (2017-2022)

6 Global Immune Checkpoint Inhibitors Market Analysis by Application
6.1 Global Immune Checkpoint Inhibitors Consumption and Market Share by Application (2017-2022)
6.2 Global Immune Checkpoint Inhibitors Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Immune Checkpoint Inhibitors Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Immune Checkpoint Inhibitors Consumption and Growth Rate of Lung Cancer (2017-2022)
6.3.2 Global Immune Checkpoint Inhibitors Consumption and Growth Rate of Breast Cancer (2017-2022)
6.3.3 Global Immune Checkpoint Inhibitors Consumption and Growth Rate of Liver Cancer (2017-2022)
6.3.4 Global Immune Checkpoint Inhibitors Consumption and Growth Rate of Gastric Cancer (2017-2022)
6.3.5 Global Immune Checkpoint Inhibitors Consumption and Growth Rate of Glioma Cancer (2017-2022)
6.3.6 Global Immune Checkpoint Inhibitors Consumption and Growth Rate of Esophageal Cancer (2017-2022)
6.3.7 Global Immune Checkpoint Inhibitors Consumption and Growth Rate of Others (2017-2022)

7 Global Immune Checkpoint Inhibitors Market Forecast (2022-2031)
7.1 Global Immune Checkpoint Inhibitors Sales Volume, Revenue Forecast (2022-2031)
7.1.1 Global Immune Checkpoint Inhibitors Sales Volume and Growth Rate Forecast (2022-2031)
7.1.2 Global Immune Checkpoint Inhibitors Revenue and Growth Rate Forecast (2022-2031)
7.1.3 Global Immune Checkpoint Inhibitors Price and Trend Forecast (2022-2031)
7.2 Global Immune Checkpoint Inhibitors Sales Volume and Revenue Forecast, Region Wise (2022-2031)
7.2.1 United States Immune Checkpoint Inhibitors Sales Volume and Revenue Forecast (2022-2031)
7.2.2 Europe Immune Checkpoint Inhibitors Sales Volume and Revenue Forecast (2022-2031)
7.2.3 China Immune Checkpoint Inhibitors Sales Volume and Revenue Forecast (2022-2031)
7.2.4 Japan Immune Checkpoint Inhibitors Sales Volume and Revenue Forecast (2022-2031)
7.2.5 India Immune Checkpoint Inhibitors Sales Volume and Revenue Forecast (2022-2031)
7.2.6 Southeast Asia Immune Checkpoint Inhibitors Sales Volume and Revenue Forecast (2022-2031)
7.2.7 Latin America Immune Checkpoint Inhibitors Sales Volume and Revenue Forecast (2022-2031)
7.2.8 Middle East and Africa Immune Checkpoint Inhibitors Sales Volume and Revenue Forecast (2022-2031)
7.3 Global Immune Checkpoint Inhibitors Sales Volume, Revenue and Price Forecast by Type (2022-2031)
7.3.1 Global Immune Checkpoint Inhibitors Revenue and Growth Rate of CTLA-4 Inhibitor (2022-2031)
7.3.2 Global Immune Checkpoint Inhibitors Revenue and Growth Rate of PD-1 Inhibitor (2022-2031)
7.3.3 Global Immune Checkpoint Inhibitors Revenue and Growth Rate of PD-L1 Inhibitor (2022-2031)
7.3.4 Global Immune Checkpoint Inhibitors Revenue and Growth Rate of Others (2022-2031)
7.4 Global Immune Checkpoint Inhibitors Consumption Forecast by Application (2022-2031)
7.4.1 Global Immune Checkpoint Inhibitors Consumption Value and Growth Rate of Lung Cancer(2022-2031)
7.4.2 Global Immune Checkpoint Inhibitors Consumption Value and Growth Rate of Breast Cancer(2022-2031)
7.4.3 Global Immune Checkpoint Inhibitors Consumption Value and Growth Rate of Liver Cancer(2022-2031)
7.4.4 Global Immune Checkpoint Inhibitors Consumption Value and Growth Rate of Gastric Cancer(2022-2031)
7.4.5 Global Immune Checkpoint Inhibitors Consumption Value and Growth Rate of Glioma Cancer(2022-2031)
7.4.6 Global Immune Checkpoint Inhibitors Consumption Value and Growth Rate of Esophageal Cancer(2022-2031)
7.4.7 Global Immune Checkpoint Inhibitors Consumption Value and Growth Rate of Others(2022-2031)
7.5 Immune Checkpoint Inhibitors Market Forecast Under COVID-19

8 Immune Checkpoint Inhibitors Market Upstream and Downstream Analysis
8.1 Immune Checkpoint Inhibitors Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Immune Checkpoint Inhibitors Analysis
8.6 Major Downstream Buyers of Immune Checkpoint Inhibitors Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Immune Checkpoint Inhibitors Industry

9 Players Profiles
9.1 Incyte Corporation
9.1.1 Incyte Corporation Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Immune Checkpoint Inhibitors Product Profiles, Application and Specification
9.1.3 Incyte Corporation Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Genentech
9.2.1 Genentech Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Immune Checkpoint Inhibitors Product Profiles, Application and Specification
9.2.3 Genentech Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Innate Pharma
9.3.1 Innate Pharma Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Immune Checkpoint Inhibitors Product Profiles, Application and Specification
9.3.3 Innate Pharma Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Bristol-Myers Squibb Company
9.4.1 Bristol-Myers Squibb Company Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Immune Checkpoint Inhibitors Product Profiles, Application and Specification
9.4.3 Bristol-Myers Squibb Company Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Novartis AG
9.5.1 Novartis AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Immune Checkpoint Inhibitors Product Profiles, Application and Specification
9.5.3 Novartis AG Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 NewLink Genetics
9.6.1 NewLink Genetics Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Immune Checkpoint Inhibitors Product Profiles, Application and Specification
9.6.3 NewLink Genetics Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Pfizer
9.7.1 Pfizer Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Immune Checkpoint Inhibitors Product Profiles, Application and Specification
9.7.3 Pfizer Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Merck & Co.
9.8.1 Merck & Co. Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Immune Checkpoint Inhibitors Product Profiles, Application and Specification
9.8.3 Merck & Co. Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Immutep
9.9.1 Immutep Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Immune Checkpoint Inhibitors Product Profiles, Application and Specification
9.9.3 Immutep Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Eli Lilly and Company (ARMO BioSciences)
9.10.1 Eli Lilly and Company (ARMO BioSciences) Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Immune Checkpoint Inhibitors Product Profiles, Application and Specification
9.10.3 Eli Lilly and Company (ARMO BioSciences) Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 Sorrento Therapeutics
9.11.1 Sorrento Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Immune Checkpoint Inhibitors Product Profiles, Application and Specification
9.11.3 Sorrento Therapeutics Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Roche
9.12.1 Roche Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Immune Checkpoint Inhibitors Product Profiles, Application and Specification
9.12.3 Roche Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
9.13 MacroGenics
9.13.1 MacroGenics Basic Information, Manufacturing Base, Sales Region and Competitors
9.13.2 Immune Checkpoint Inhibitors Product Profiles, Application and Specification
9.13.3 MacroGenics Market Performance (2017-2022)
9.13.4 Recent Development
9.13.5 SWOT Analysis
9.14 Fortress Biotech, Inc. (Checkpoint Therapeutics, Inc.)
9.14.1 Fortress Biotech, Inc. (Checkpoint Therapeutics, Inc.) Basic Information, Manufacturing Base, Sales Region and Competitors
9.14.2 Immune Checkpoint Inhibitors Product Profiles, Application and Specification
9.14.3 Fortress Biotech, Inc. (Checkpoint Therapeutics, Inc.) Market Performance (2017-2022)
9.14.4 Recent Development
9.14.5 SWOT Analysis
9.15 Argenx
9.15.1 Argenx Basic Information, Manufacturing Base, Sales Region and Competitors
9.15.2 Immune Checkpoint Inhibitors Product Profiles, Application and Specification
9.15.3 Argenx Market Performance (2017-2022)
9.15.4 Recent Development
9.15.5 SWOT Analysis
9.16 CureTech
9.16.1 CureTech Basic Information, Manufacturing Base, Sales Region and Competitors
9.16.2 Immune Checkpoint Inhibitors Product Profiles, Application and Specification
9.16.3 CureTech Market Performance (2017-2022)
9.16.4 Recent Development
9.16.5 SWOT Analysis
9.17 GlaxoSmithKline
9.17.1 GlaxoSmithKline Basic Information, Manufacturing Base, Sales Region and Competitors
9.17.2 Immune Checkpoint Inhibitors Product Profiles, Application and Specification
9.17.3 GlaxoSmithKline Market Performance (2017-2022)
9.17.4 Recent Development
9.17.5 SWOT Analysis
9.18 Immune Therapeutics
9.18.1 Immune Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
9.18.2 Immune Checkpoint Inhibitors Product Profiles, Application and Specification
9.18.3 Immune Therapeutics Market Performance (2017-2022)
9.18.4 Recent Development
9.18.5 SWOT Analysis
9.19 Celldex Therapeutics (Avant Immunotherapeutics, Inc.)
9.19.1 Celldex Therapeutics (Avant Immunotherapeutics, Inc.) Basic Information, Manufacturing Base, Sales Region and Competitors
9.19.2 Immune Checkpoint Inhibitors Product Profiles, Application and Specification
9.19.3 Celldex Therapeutics (Avant Immunotherapeutics, Inc.) Market Performance (2017-2022)
9.19.4 Recent Development
9.19.5 SWOT Analysis
9.20 AstraZeneca
9.20.1 AstraZeneca Basic Information, Manufacturing Base, Sales Region and Competitors
9.20.2 Immune Checkpoint Inhibitors Product Profiles, Application and Specification
9.20.3 AstraZeneca Market Performance (2017-2022)
9.20.4 Recent Development
9.20.5 SWOT Analysis
9.21 GITR, Inc.
9.21.1 GITR, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.21.2 Immune Checkpoint Inhibitors Product Profiles, Application and Specification
9.21.3 GITR, Inc. Market Performance (2017-2022)
9.21.4 Recent Development
9.21.5 SWOT Analysis
9.22 Seattle Genetics
9.22.1 Seattle Genetics Basic Information, Manufacturing Base, Sales Region and Competitors
9.22.2 Immune Checkpoint Inhibitors Product Profiles, Application and Specification
9.22.3 Seattle Genetics Market Performance (2017-2022)
9.22.4 Recent Development
9.22.5 SWOT Analysis

10 Research Findings and Conclusion

11 Appendix
11.1 Methodology
11.2 Research Data Source